MID-LIFE ANTI-HYPERTENSIVE TREATMENT MAY NOT NORMALIZE LEFT VENTRICULAR MASS IN SPITE OF CONTROLLED BLOOD PRESSURE

In cross-sectional studies, elevated systolic blood pressure (SBP) is associated with increased left ventricular mass (LVM), which leads to increased cardiovascular morbidity and mortality. Current guidelines recommend a “watch and wait” approach in younger individuals with a borderline-